Cite
HARVARD Citation
Tang, A. et al. (2019). Characterizing complication risk from multisite, intermittent transfusions for the treatment of sickle cell disease. Pediatric blood & cancer. 66 (10), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Tang, A. et al. (2019). Characterizing complication risk from multisite, intermittent transfusions for the treatment of sickle cell disease. Pediatric blood & cancer. 66 (10), p. n/a. [Online].